Attovia Therapeutics | $105,000,000 | (May 14, 2024)
Glacis Labs | $2,000,000 | (May 14, 2024)
hexafarms | $1,403,746 | (May 14, 2024)
Excarta
United States
- San Francisco Bay Area, CA
- 20/12/2023
- Seed
- $2,500,000
Excarta uses cutting-edge AI research to make businesses more resilient to volatile weather.
Excarta's AI-powered weather models provide higher accuracy and better resolution than conventional weather models, and translate those forecasts into actionable intelligence.
- Industry Software Development
- Website https://excarta.io/
- LinkedIn https://www.linkedin.com/company/excarta/about/
Related People
Vivek RamavajjalaFounder
United States -
Mountain View, California
I'm passionate about using technology in general, and AI specifically, to make our world a better place to live in (not just for humans).
I enjoy finding ways to use ML to solve meaningful problems in a meaningful way. Currently, I'm a founder at Excarta, providing AI-powered weather forecasts. Previously, I spent ~10 years at Google and DeepMind solving product problems with applied ML and engineering. I pride myself on building highly effective Research Engineering teams that effectively utilize ML to solve high-impact, large-scale product problems.
CereVasc | $70,000,000 | (May 14, 2024)
GigPig | $1,631,441 | (May 14, 2024)
Active Surfaces | $5,600,000 | (May 14, 2024)
May Health | $25,000,000 | (May 14, 2024)
ByHeart | $95,000,000 | (May 14, 2024)
tiney | $9,034,812 | (May 14, 2024)
Hexis | $2,009,680 | (May 14, 2024)
Nivoda | $30,000,000 | (May 14, 2024)
Switchboard Health | $6,500,000 | (May 14, 2024)